March 8 (SeeNews) - Croatian pharmaceuticals producer Jadran Galenski Laboratorij (JGL) [ZSE:JDGL-O-166A, JDGL-O-126A] posted an all-time high consolidated after-tax profit of 105.7 million kuna ($15 million/14 million euro) last year, it said on Tuesday.